Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2018 Oct 9;93(7):E385–E390. doi: 10.1002/ccd.27915

Table 3: Demographics and risk factors of the patients with HDAVB who underwent permanent pacemaker implantation versus those did not.

Pacemaker (n=2,580) No pacemaker (n=900) p-value
Age (mean ±standard deviation) 82 ± 8 82 ± 8 0.64
Male 52.1% 47.2% 0.23
Race White 82.8% 82.2% 0.86
Hypertension 80.0% 76.7% 0.27
Diabetes 38.8% 33.3% 0.19
Dyslipidemia 65.5% 55.0% 0.01
Current smoking 2.7% 2.8% 0.96
Obesity 16.3% 9.4% 0.01
Coronary artery disease 29.7% 31.7% 0.58
Prior PCI 18.0% 15.6% 0.37
Prior CABG 19.8% 15.6% 0.13
Prior stroke/TIA 11.6% 7.8% 0.11
Anemia 25.6% 24.4% 0.71
Renal failure 40.1% 37.2% 0.45
Chronic pulmonary disease 32.8% 31.7% 0.78
Peripheral vascular disease 28.9% 30.0% 0.74
Atrial fibrillation 38.0% 42.2% 0.22
In-hospital mortality 3.1% 12.2% <0.001

CABG: coronary artery bypass grafting, PCI: percutaneous coronary intervention, TAVI: trans-catheter aortic valve implantation, TIA: transient ischemic attack,